TB

This report provides recommendations from the Advisory Council for the Elimination of TB (ACET) concerning TB elimination in low-incidence areas. In 1999, ACET called for a renewed commitment to its strategic plan, originally published in 1989 with a year 2000 objective of 3.5 cases per 100,000 population. Also in 2000, the Institute of Medicine proposed a comprehensive action plan for TB elimination in the United States. In 2000, 22 states reported incidence rates of =3.5/100,000, which was the objective set by ACET in its 1989 strategic plan.

These tools are primarily for urban TB programs wishing to improve secondary prevention of TB in those groups at high risk of progression to TB disease, including the homeless, chemically dependent, and mentally ill. The materials include sample letters, forms, and job descriptions and protocols as well as templates of these tools for adaptation to local programs. The templates are Microsoft Word files so you can customize these templates for your own program. Most of the samples and resources are PDF files so you will need a version of Adobe Acrobat Reader in order to open them.

This brochure explains the connection between tuberculosis and queso fresco.

This report summarizes data from the national TB surveillance system for 2000 and compares them with data from 1992 to 1999.

This report discusses the burdens of AIDS, malaria, and TB; assesses the tools used to fight them; identifies barriers to success; and provides statistics on deaths caused by these diseases in 2000.

This document reinforces the five essential elements of the DOTS strategy.

The Global MDR-TB and XDR-TB Response Plan 2007-2008 sets out measures needed now to prevent, treat and control extensively drug-resistant TB (XDR-TB) and multidrug-resistant TB (MDR-TB). The plan also sets in motion actions to reach a 2015 goal of providing access to drugs and diagnostic tests to all MDR-TB and XDR-TB patients, saving the lives of up to 1.2 million patients.

This is a fact sheet for policymakers on MDR and XDR TB.

This is a fact sheet in French for policymakers on MDR and XDR TB.

This framework identifies key issues that need to be addressed to accelerate the adoption and implementation of new and improved technologies. It provides guidance on what actions are needed when improved existing and/or new medicines, diagnostics and vaccines become available.

The document identifies challenges to retooling and proposes key steps for facilitating appropriate and timely adoption and implementation. It also provides an overview of technical and operational considerations for retooling at global and national levels.